Events

Security Research Event: Boosting security through EU-based innovation
JUN
Tue
24
JUN
Wed
25

This was 5 months ago

Location

Warsaw, Poland

12/14 Prądzyńskiego Street
01-222 Warsaw
Programmes
Security

The Security Research Event (SRE) is the forum where industry, policy makers, safety and security practitioners, knowledge institutions and critical infrastructure operators discuss security threats and challenges, and how EU research and innovation can contribute to tackle them.

The main theme of 2025 edition is Boosting security through EU-based innovation. Five thematic panels will provide the opportunity to discuss how to achieve the identified goals while ensuring the European strategic autonomy.

For more information on the content of the event, its agenda and to register, please visit the event website

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.